Efficacy of triple therapy to eradicate H. pylori in duodenal ulcer patients after failure of omeprazole/amoxicillin;WIRKSAMKEIT DER TRIPELTHERAPIE SUR ERADIKATION VON H. PYLORI BEI THERAPIEVERSAGERN MIT OMEPRAZOL/AMOXICILLIN

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 5, 1996, Pages 153-158

  Zala, G ^a   Schwery, St ^a   Giezendanner, S ^c   Flury, R ^b   Wust J ^c   Meyenberger, Ch ^a   Wirth, H P ^a  

^a Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; BISMUTH CITRATE; OMEPRAZOLE; ORNIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; ORGANOMETALLIC COMPOUND;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DUODENUM ULCER; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; ADULT; DRUG COMBINATION; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; TETRACYCLINE; TREATMENT OUTCOME;

EID: 0029666332     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-S128.
2. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
3. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T: The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76-89.
4. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ et al.: Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-260.
5. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ et al.: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 705-708.
6. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H et al.: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
7. De Koster E, Nyst JF, Deprez C, Jones C, Denis P et al.: HP treatment: disappointing results with amoxicillin plus omeprazole. Gastroenterology 1992; 102: A58.
8. Collins R, Beattie S, O'Morain C: High dose omeprazole plus amoxicillin in the treatment of acute duodenal ulcer. Ir J Med Sci 1992; 161 (Suppl. 10): 96-97.
9. Logan RPH, Rubio MA, Gummet PA, Hegarty B, Walker MM et al.: Omeprazole and amoxicillin suspension for Helicobacter pylori. Ir J Med Sci 1992; 161 (Suppl. 10): 16.
10. Schaufelberger HD, Logan RPH, Gummet PA, Baron JH, Misiewicz JJ: The effect of patient compliance on Helicobacter pylori eradication with dual therapy. Proceedings of the II United European Gastroenterology Week, Barcelona 1993: A98.
11. Unge P, Gad A, Eriksson K, Bergman B, Carling L et al.: Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993; 5: 325-331.
12. Wagner S, Bleck J, Gebel M, Bär W, Manns M: What treatment is best for gastric Helicobacter pylori infection. Ir J Med Sci 1992; 161 (Suppl. 10): 16.
13. Unge P, Gad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? Scand J Gastroenterol 1989; 24 (Suppl. 167): 49-54.
14. Labenz J, Geynes E, Rühl GH, Börsch G: Omeprazole plus amoxicillin: Efficacy of various regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-495.
15. Labenz J, Geynes E, Rühl GH, Börsch G: Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993; 34: 1167-1170.
16. Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J et al.: High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. European J Gastroenterol Hepatol 1992; 4: 697-702.
17. Adamek RJ, Wegener M, Birkholz S, Opferkuch W, Rühl GH, Ricken D: Modifizierte kombinierte Omeprazol/Amoxicillin-Therapie zur Helicobacter-pylori-Eradikation: eine Pilotstudie. Leber Magen Darm 1992; 22: 222-224.
18. Zala G, Wirth HP, Giezendanner S, Flury R, Wüst J et al.: Omeprazole/amoxicillin: Impaired eradication of H. pylori by smoking but not by omeprazole pretreatment. Gastroenterology 1994; 106: A215.
19. Zala G, Giezendanner S, Flury R, Wüst J, Meyenberger Ch, Wirth HP: Omeprazol/Amoxicillin: beeinträchtigte Eradikation von Helicobacter pylori durch Rauchen, aber nicht durch eine Omeprazol-Vorbehandlung. Schweiz Med Wochenschr 1994; 124: 1398-1404.
20. Atherton JC, Hawkey CJ, Spiller RC: Retreatment of Helicobacter pylori infection with amoxycillin and omeprazole in patients failing this regime is less successful than initial treatment. Gastroenterology 1994; 106: A42.
21. Labenz J, Rühl GH, Bertrams J, Sollböhmer M, Tillenburg B, Börsch G: Retreatment after failure of omeprazole plus amoxicillin to cure H. pylori infection in peptic ulcer disease. Gastroenterology 1994; 106: A115.
22. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29: 2072-2075.
23. Koelz HR, Beglinger C, Inauen W, Blum AL; Helicoswiss-Studiengruppe: Doppelblinder Vergleich von drei Therapieschemen mit Amoxicillin und Omeprazol bei Patienten mit Helicobacter pylori-positivem peptischem Ulkus. Schweiz Med Wochenschr 1995; 125: Suppl. 71: 6S.
24. Graham DY: 3 drugs or 2; 2 weeks or 1: the ideal treatment for H. pylori in Evolving Concepts in Gastrointestinal and Liver Diseases. Syllabus of the Postgraduate Course of the American Gastroenterological Association 1995: 257-264.
25. Xia HX, Daw MA, Beattie S, Keane CT, O'Morain CA: The influence of metronidazole resistance on triple therapy for Helicobacter pylori associated duodenal ulcer. Gastroenterology 1992; 102: A947.
26. Rautelin H, Seppälä K, Renkonen OV, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemotherapy 1992; 36: 163-166.
27. Durette A, Glupczynski Y, Deprez C: Two weeks triple therapy for Helicobacter pylori overcomes metronidazole resistance. Results of a randomized double/triple therapy. Gastroenterology 1992; 102: A46.
28. European Study Group on Antibiotic Susceptibility of Helicobacter pylori: Results of a multicentre european survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-781.
29. Glupczynski Y, Burette A: Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545-1551.